Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs SciSparc Ltd. (SPRC)

Bone Biologics Corp. and SciSparc Ltd. are both Biotechnology companies. Bone Biologics Corp. is the larger, with a market value of $1.1M against $880.0K — 1.2× the size. Across the 8 metrics below, Bone Biologics Corp. leads on 5 and SciSparc Ltd. on 3.

Valuation

Metric BBLG SPRC Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.20 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.13 0.66
EV/Sales n/m n/m 9.02
Earnings yield (438.22%) (17,380.49%) (32.88%)
Free cash flow yield (214.89%) (160,955,097.92%) (23.13%)

Profitability

Metric BBLG SPRC Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.49%) 0.00% (51.96%)
Return on assets (44.46%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG SPRC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 90.85% 51.90% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG SPRC Biotechnology median
Debt to equity 0.00 0.24 0.00
Current ratio 13.38 0.87 4.97
Net debt to EBITDA 1.65 0.52 1.01

Dividend

Metric BBLG SPRC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBLG SPRC Biotechnology median
Market cap 1.10m 880.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack